These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 38677269)

  • 1. Dihydrotanshinone I inhibits gallbladder cancer growth by targeting the Keap1-Nrf2 signaling pathway and Nrf2 phosphorylation.
    Li Z; Mo RL; Gong JF; Han L; Wang WF; Huang DK; Xu JG; Sun YJ; Chen S; Han GC; Sun DQ
    Phytomedicine; 2024 Jul; 129():155661. PubMed ID: 38677269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dihydrotanshinone I inhibits ovarian tumor growth by activating oxidative stress through Keap1-mediated Nrf2 ubiquitination degradation.
    Sun C; Han B; Zhai Y; Zhao H; Li X; Qian J; Hao X; Liu Q; Shen J; Kai G
    Free Radic Biol Med; 2022 Feb; 180():220-235. PubMed ID: 35074488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. aPKCι promotes gallbladder cancer tumorigenesis and gemcitabine resistance by competing with Nrf2 for binding to Keap1.
    Tian L; Lu Y; Yang T; Deng Z; Xu L; Yao W; Ma C; Li X; Zhang J; Liu Y; Wang J
    Redox Biol; 2019 Apr; 22():101149. PubMed ID: 30822690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 13-Acetoxysarcocrassolide Exhibits Cytotoxic Activity Against Oral Cancer Cells Through the Interruption of the Keap1/Nrf2/p62/SQSTM1 Pathway: The Need to Move Beyond Classical Concepts.
    Liu YC; Peng BR; Hsu KC; El-Shazly M; Shih SP; Lin TE; Kuo FW; Chou YC; Lin HY; Lu MC
    Mar Drugs; 2020 Jul; 18(8):. PubMed ID: 32718084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrine inhibits invasion and migration of gallbladder cancer via regulating the PI3K/AKT signaling pathway.
    Mo RL; Li Z; Zhang P; Sheng MH; Han GC; Sun DQ
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Oct; 397(10):8129-8143. PubMed ID: 38789637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WNK1 Interaction with KEAP1 Promotes NRF2 Stabilization to Enhance the Oxidative Stress Response in Hepatocellular Carcinoma.
    Li L; Xie D; Yu S; Ma M; Fan K; Chen J; Xiu M; Xie K; Li Y; Gao Y
    Cancer Res; 2024 Sep; 84(17):2776-2791. PubMed ID: 38885324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethanol extract of Eclipta prostrata induces multiple myeloma ferroptosis via Keap1/Nrf2/HO-1 axis.
    Li W; Yin X; Fu H; Liu J; Weng Z; Mao Q; Zhu L; Fang L; Zhang Z; Ding B; Tong H
    Phytomedicine; 2024 Jun; 128():155401. PubMed ID: 38507850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MDA-7/IL-24 inhibits Nrf2-mediated antioxidant response through activation of p38 pathway and inhibition of ERK pathway involved in cancer cell apoptosis.
    Tian H; Zhang D; Gao Z; Li H; Zhang B; Zhang Q; Li L; Cheng Q; Pei D; Zheng J
    Cancer Gene Ther; 2014 Oct; 21(10):416-26. PubMed ID: 25236495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNFAIP2 confers cisplatin resistance in head and neck squamous cell carcinoma via KEAP1/NRF2 signaling.
    Xu T; Yang Y; Chen Z; Wang J; Wang X; Zheng Y; Wang C; Wang Y; Zhu Z; Ding X; Zhou J; Li G; Zhang H; Zhang W; Wu Y; Song X
    J Exp Clin Cancer Res; 2023 Aug; 42(1):190. PubMed ID: 37525222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The discovery and characterization of K-563, a novel inhibitor of the Keap1/Nrf2 pathway produced by Streptomyces sp.
    Hori R; Yamaguchi K; Sato H; Watanabe M; Tsutsumi K; Iwamoto S; Abe M; Onodera H; Nakamura S; Nakai R
    Cancer Med; 2019 Mar; 8(3):1157-1168. PubMed ID: 30735010
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Peng LY; An L; Sun NY; Ma Y; Zhang XW; Liu WH; Liu BL; Li P; Chen J
    Am J Chin Med; 2019; 47(5):1113-1131. PubMed ID: 31352786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formononetin, a bioactive isoflavonoid constituent from Astragalus membranaceus (Fisch.) Bunge, ameliorates type 1 diabetes mellitus via activation of Keap1/Nrf2 signaling pathway: An integrated study supported by network pharmacology and experimental validation.
    Chen H; Lou Y; Lin S; Tan X; Zheng Y; Yu H; Jiang R; Wei Y; Huang H; Qi X; Zhang R; Liu Z; Wu J
    J Ethnopharmacol; 2024 Mar; 322():117576. PubMed ID: 38104880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Esculetin induces antiproliferative and apoptotic response in pancreatic cancer cells by directly binding to KEAP1.
    Arora R; Sawney S; Saini V; Steffi C; Tiwari M; Saluja D
    Mol Cancer; 2016 Oct; 15(1):64. PubMed ID: 27756327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LKB1 and KEAP1/NRF2 Pathways Cooperatively Promote Metabolic Reprogramming with Enhanced Glutamine Dependence in
    Galan-Cobo A; Sitthideatphaiboon P; Qu X; Poteete A; Pisegna MA; Tong P; Chen PH; Boroughs LK; Rodriguez MLM; Zhang W; Parlati F; Wang J; Gandhi V; Skoulidis F; DeBerardinis RJ; Minna JD; Heymach JV
    Cancer Res; 2019 Jul; 79(13):3251-3267. PubMed ID: 31040157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer.
    Shibata T; Kokubu A; Gotoh M; Ojima H; Ohta T; Yamamoto M; Hirohashi S
    Gastroenterology; 2008 Oct; 135(4):1358-1368, 1368.e1-4. PubMed ID: 18692501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dihydrotanshinone I Inhibits Pancreatic Cancer Progression
    Huang W; Dai Y; Xu L; Mao Y; Huang Z; Ji X
    Curr Cancer Drug Targets; 2023; 23(9):731-741. PubMed ID: 37018533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis.
    Roh JL; Kim EH; Jang H; Shin D
    Redox Biol; 2017 Apr; 11():254-262. PubMed ID: 28012440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamoxifen inhibits cell proliferation by impaired glucose metabolism in gallbladder cancer.
    Huang S; Wang H; Chen W; Zhan M; Xu S; Huang X; Lin R; Shen H; Wang J
    J Cell Mol Med; 2020 Jan; 24(2):1599-1613. PubMed ID: 31782270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Icaritin activates Nrf2/Keap1 signaling to protect neuronal cells from oxidative stress.
    Xu Y; Lu X; Zhang L; Wang L; Zhang G; Yao J; Sun C
    Chem Biol Drug Des; 2021 Jan; 97(1):111-120. PubMed ID: 32654377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EGFR-Targeted Immunotoxin Exerts Antitumor Effects on Esophageal Cancers by Increasing ROS Accumulation and Inducing Apoptosis via Inhibition of the Nrf2-Keap1 Pathway.
    Yang Y; Tian Z; Ding Y; Li X; Zhang Z; Yang L; Zhao F; Ren F; Guo R
    J Immunol Res; 2018; 2018():1090287. PubMed ID: 30596104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.